The 100 most cited publications in cardiac surgery: a bibliometric analysis

Irish Journal of Medical Science

Volumn 184, Issue 1, 2015, Pages 91-99

  O'Sullivan K E ^a,b   Kelly, J C ^a,b   Hurley, J P ^a,b  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^b MATER PRIVATE HOSPITAL   (Ireland)

Author keywords

Bibliometric analysis; Cardiac; Surgery

Indexed keywords

ANESTHESIA; AUTHOR; BIBLIOMETRICS; CITATION ANALYSIS; EUROSCORE; GENERAL PRACTICE; HEART ATRIUM FIBRILLATION; HEART SURGERY; HUMAN; MEDICAL SOCIETY; PATHOLOGY; PERFUSION; PUBLICATION; REVIEW; THORAX SURGERY; JOURNAL IMPACT FACTOR; PUBLISHING; STATISTICS AND NUMERICAL DATA;

BIBLIOMETRICS; CARDIAC SURGICAL PROCEDURES; HUMANS; JOURNAL IMPACT FACTOR; PUBLISHING;

EID: 84925935478     PISSN: 00211265     EISSN: 18634362     Source Type: Journal    
DOI: 10.1007/s11845-014-1193-1     Document Type: Review

References (113)

1. Kelly JC, Glynn RW, O’Briain DE, Felle P, McCabe JP (2010) The 100 classic papers of orthopaedic surgery: a bibliometric analysis. J Bone Joint Surg Br 92(10):1338–1343
2. Eyre-Walker A, Stoletzki N (2013) The assessment of science: the relative merits of post-publication review, the impact factor, and the number of citations. PLoS Biol 11(10):e1001675
3. Baltussen A, Kindler CH (2004) Citation classics in anesthetic journals. Anesth Analg 98(2):443–451
4. Dubin D, Hafner AW, Arndt KA (1993) Citation classics in clinical dermatologic journals. Citation analysis, biomedical journals, and landmark articles, 1945–1990. Arch Dermatol 129(9):1121–1129
5. Paladugu R, Schein M, Gardezi S, Wise L (2002) One hundred citation classics in general surgical journals. World J Surg 26(9):1099–1105
6. Loonen MP, Hage JJ, Kon M (2008) Plastic surgery classics: characteristics of 50 top-cited articles in four plastic surgery journals since 1946. Plast Reconstr Surg 121(5):320e–327e
7. Loonen MP, Hage JJ, Kon M (2007) Value of citation numbers and impact factors for analysis of plastic surgery research. Plast Reconstr Surg 120(7):2082–2091 (discussion 92–94, Comparative Study)
8. Bosker BH, Verheyen CC (2006) The international rank order of publications in major clinical orthopaedic journals from 2000 to 2004. J Bone Joint Surg Br 88(2):156–158
9. Fenton JE, Roy D, Hughes JP, Jones AS (2002) A century of citation classics in otolaryngology-head and neck surgery journals. J Laryngol Otol 116(7):494–498
10. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R (1999) European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 16(1):9–13
11. Kodali SK, Williams MR, Smith CR et al (2012) Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 366(18):1686–1695
12. Bigelow WG, Callaghan JC, Hopps JA (1950) General hypothermia for experimental intracardiac surgery; the use of electrophrenic respirations, an artificial pacemaker for cardiac standstill and radio-frequency rewarming in general hypothermia. Ann Surg 132(3):531–539
13. Leon MB, Smith CR, Mack M et al (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363(17):1597–1607
14. Webb JG, Pasupati S, Humphries K et al (2007) Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 116(7):755–763
15. Thomas M, Schymik G, Walther T et al (2010) Thirty-day results of the SAPIEN aortic bioprosthesis European outcome (SOURCE) registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 122(1):62–69
16. Tamburino C, Capodanno D, Ramondo A et al (2011) Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 123(3):299–308
17. Lichtenstein SV, Cheung A, Ye J et al (2006) Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation 114(6):591–596
18. Webb JG, Altwegg L, Boone RH et al (2009) Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation 119(23):3009–3016
19. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease (1996) The bypass angioplasty revascularization investigation (BARI) investigators. N Engl J Med 335(4):217–225
20. Alderman EL, Fisher LD, Litwin P et al (1983) Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 68(4):785–795
21. Alderman EL, Bourassa MG, Cohen LS et al (1990) Ten-year follow-up of survival and myocardial infarction in the randomized coronary artery surgery study. Circulation 82(5):1629–1646
22. Carpentier A (1983) Cardiac valve surgery–the “French correction”. J Thorac Cardiovasc Surg 86(3):323–337
23. Carpentier A, Chauvaud S, Fabiani JN et al (1980) Reconstructive surgery of mitral valve incompetence: ten-year appraisal. J Thorac Cardiovasc Surg 79(3):338–348
24. Carpentier A, Deloche A, Dauptain J et al (1971) A new reconstructive operation for correction of mitral and tricuspid insufficiency. J Thorac Cardiovasc Surg 61(1):1–13
25. Cox JL, Boineau JP, Schuessler RB, Kater KM, Lappas DG (1993) Five-year experience with the maze procedure for atrial fibrillation. Ann Thorac Surg 56(4):814–823 (discussion 23–24)
26. Cox JL, Canavan TE, Schuessler RB et al (1991) The surgical treatment of atrial fibrillation. II. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation. J Thorac Cardiovasc Surg 101(3):406–426
27. Cox JL, Schuessler RB, D’Agostino HJ et al (1991) The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. J Thorac Cardiovasc Surg 101(4):569–583
28. Lytle BW, Loop FD, Cosgrove DM, Ratliff NB, Easley K, Taylor PC (1985) Long-term (5 to 12 years) serial studies of internal mammary artery and saphenous vein coronary bypass grafts. J Thorac Cardiovasc Surg 89(2):248–258
29. Motwani JG, Topol EJ (1998) Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 97(9):916–931
30. Koch CG, Li L, Sessler DI et al (2008) Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 358(12):1229–1239
31. Loop FD, Lytle BW, Cosgrove DM, Mahfood S, McHenry MC, Goormastic M, J. Maxwell Chamberlain memorial paper et al (1990) Sternal wound complications after isolated coronary artery bypass grafting: early and late mortality, morbidity, and cost of care. Ann Thorac Surg 49(2):179–186 (discussion 86–87)
32. Cosgrove DM, 3rd, Heric B, Lytle BW et al (1992) Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study. Ann Thorac Surg 54(6):1031–1036 (discussion 6–8)
33. Lytle BW, Blackstone EH, Loop FD et al (1999) Two internal thoracic artery grafts are better than one. J Thorac Cardiovasc Surg 117(5):855–872
34. Bigelow WG, Lindsay WK, Greenwood WF (1950) Hypothermia; its possible role in cardiac surgery: an investigation of factors governing survival in dogs at low body temperatures. Ann Surg 132(5):849–866
35. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD (1983) Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 86(6):845–857
36. Bidstrup BP, Royston D, Sapsford RN, Taylor KM (1989) Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). J Thorac Cardiovasc Surg 97(3):364–372
37. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A (1999) Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 67(2):352–360 (discussion 60–62)
38. Coronary angioplasty versus coronary artery bypass surgery: the Randomized Intervention Treatment of Angina (RITA) trial. Lancet. 1993;341(8845):573-80
39. David TE, Feindel CM. An aortic valve-sparing operation for patients with aortic incompetence and aneurysm of the ascending aorta. J Thorac Cardiovasc Surg. 1992;103(4):617-21; discussion 22
40. Puskas JD, Williams WH, Duke PG et al (2003) Off-pump coronary artery bypass grafting provides complete revascularization with reduced myocardial injury, transfusion requirements, and length of stay: a prospective randomized comparison of two hundred unselected patients undergoing off-pump versus conventional coronary artery bypass grafting. J Thorac Cardiovasc Surg 125(4):797–808
41. Pepe A, Kurtz MJ (2012) A measure of total research impact independent of time and discipline. PLoS ONE 7(11):e46428
42. van Eck NJ, Waltman L, van Raan AF, Klautz RJ, Peul WC (2013) Citation analysis may severely underestimate the impact of clinical research as compared to basic research. PLoS ONE 8(4):e62395
43. Winnik S, Raptis DA, Walker JH et al (2012) From abstract to impact in cardiovascular research: factors predicting publication and citation. Eur Heart J 33(24):3034–3045
44. Davies MK, Hollman A (2002) History of cardiac surgery. Heart 87(6):509
45. Kolessov VI (1967) Mammary artery-coronary artery anastomosis as method of treatment for angina pectoris. J Thorac Cardiovasc Surg 54(4):535–544
46. Rahimtoola SH (1985) A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation 72(6 Pt 2):V123–V135
47. van de Watering LM, Hermans J, Houbiers JG et al (1998) Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation 97(6):562–568
48. Roach GW, Kanchuger M, Mangano CM et al (1996) Adverse cerebral outcomes after coronary bypass surgery. Multicenter study of perioperative ischemia research group and the ischemia research and education foundation investigators. N Engl J Med 335(25):1857–1863
49. McFalls EO, Ward HB, Moritz TE et al (2004) Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 351(27):2795–2804
50. Angelini GD, Taylor FC, Reeves BC, Ascione R (2002) Early and midterm outcome after off-pump and on-pump surgery in beating heart against cardioplegic arrest studies (BHACAS 1 and 2): a pooled analysis of two randomised controlled trials. Lancet 359(9313):1194–1199
51. Yusuf S, Zucker D, Peduzzi P et al (1994) Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the coronary artery bypass graft surgery trialists collaboration. Lancet 344(8922):563–570
52. Ross DN (1967) Replacement of aortic and mitral valves with a pulmonary autograft. Lancet 2(7523):956–958
53. Debakey ME, Henly WS, Cooley DA, Morris GC Jr, Crawford ES, Beall AC Jr (1965) Surgical management of dissecting aneurysms of the aorta. J Thorac Cardiovasc Surg 49:130–149
54. Serruys PW, Morice MC, Kappetein AP et al (2009) Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 360(10):961–972
55. Ross DN (1962) Homograft replacement of the aortic valve. Lancet 2(7254):487
56. Hannan EL, Racz MJ, Walford G, Jones RH, Ryan TJ, Bennett E et al (2005) Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med 352(21):2174–2183 (Comparative Study)
57. Furnary AP, Gao G, Grunkemeier GL et al (2003) Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 125(5):1007–1021
58. Buckberg GD (1979) A proposed “solution” to the cardioplegic controversy. J Thorac Cardiovasc Surg 77(6):803–815
59. Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW (1981) Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 304(9):497–503
60. Acar C, Jebara VA, Portoghese M et al (1992) Revival of the radial artery for coronary artery bypass grafting. Ann Thorac Surg 54(4):652–659 (discussion 9–60)
61. Gardner TJ, Horneffer PJ, Manolio TA, Pearson TA, Gott VL, Baumgartner WA et al (1985) Stroke following coronary artery bypass grafting: a ten-year study. Ann Thorac Surg 40(6):574–581
62. Guiraudon G, Fontaine G, Frank R, Escande G, Etievent P, Cabrol C (1978) Encircling endocardial ventriculotomy: a new surgical treatment for life-threatening ventricular tachycardias resistant to medical treatment following myocardial infarction. Ann Thorac Surg 26(5):438–444
63. Newman MF, Kirchner JL, Phillips-Bute B et al (2001) Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med 344(6):395–402
64. Ferguson TB, Jr, Hammill BG, Peterson ED, DeLong ER, Grover FL (2002) A decade of change–risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990–1999: a report from the STS National Database Committee and the Duke Clinical Research Institute. Society of Thoracic Surgeons. Ann Thorac Surg 73(2):480–489 (discussion 9-90)
65. Mishra J, Dent C, Tarabishi R et al (2005) Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365(9466):1231–1238
66. Buffolo E, de Andrade CS, Branco JN, Teles CA, Aguiar LF, Gomes WJ (1996) Coronary artery bypass grafting without cardiopulmonary bypass. Ann Thorac Surg 61(1):63–66
67. Griepp RB, Stinson EB, Hollingsworth JF, Buehler D (1975) Prosthetic replacement of the aortic arch. J Thorac Cardiovasc Surg 70(6):1051–1063
68. Inoue K, Owaki T, Nakamura T, Kitamura F, Miyamoto N (1984) Clinical application of transvenous mitral commissurotomy by a new balloon catheter. J Thorac Cardiovasc Surg 87(3):394–402
69. Smith CR, Leon MB, Mack MJ et al (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364(23):2187–2198
70. Khan NE, De Souza A, Mister R et al (2004) A randomized comparison of off-pump and on-pump multivessel coronary-artery bypass surgery. N Engl J Med 350(1):21–28
71. Roques F, Nashef SA, Michel P et al (1999) Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 15(6):816–822 (discussion 22–23)
72. Hamm CW, Reimers J, Ischinger T, Rupprecht HJ, Berger J, Bleifeld W (1994) A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation (GABI). N Engl J Med 331(16):1037–1043
73. Calafiore AM, Giammarco GD, Teodori G et al (1996) Left anterior descending coronary artery grafting via left anterior small thoracotomy without cardiopulmonary bypass. Ann Thorac Surg 61(6):1658–1663 (discussion 64–65)
74. Steingart RM, Packer M, Hamm P et al (1991) Sex differences in the management of coronary artery disease. Survival and ventricular enlargement investigators. N Engl J Med 325(4):226–230
75. Parsonnet V, Dean D, Bernstein AD (1989) A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation 79(6 Pt 2):I3–I12
76. Shroyer AL, Grover FL, Hattler B et al (2009) On-pump versus off-pump coronary-artery bypass surgery. N Engl J Med 361(19):1827–1837
77. Kennedy JW, Kaiser GC, Fisher LD et al (1981) Clinical and angiographic predictors of operative mortality from the collaborative study in coronary artery surgery (CASS). Circulation 63(4):793–802
78. van Oeveren W, Harder MP, Roozendaal KJ, Eijsman L, Wildevuur CR (1990) Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. J Thorac Cardiovasc Surg 99(5):788–796 (discussion 96–97)
79. Takaro T, Hultgren HN, Lipton MJ, Detre KM (1976) The VA cooperative randomized study of surgery for coronary arterial occlusive disease II. Subgroup with significant left main lesions. Circulation 54(6 Suppl):III107–III117
80. Fergusson DA, Hebert PC, Mazer CD et al (2008) A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 358(22):2319–2331
81. Serruys PW, Unger F, Sousa JE et al (2001) Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 344(15):1117–1124
82. Peterson ED, Shaw LK, DeLong ER, Pryor DB, Califf RM, Mark DB (1997) Racial variation in the use of coronary-revascularization procedures. Are the differences real? Do they matter? N Engl J Med 336(7):480–486
83. Mangano DT (2002) Aspirin and mortality from coronary bypass surgery. N Engl J Med 347(17):1309–1317
84. Mangano DT, Tudor IC, Dietzel C (2006) The risk associated with aprotinin in cardiac surgery. N Engl J Med 354(4):353–365
85. Pocock SJ, Henderson RA, Rickards AF et al (1995) Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet 346(8984):1184–1189
86. Nussmeier NA, Whelton AA, Brown MT et al (2005) Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med 352(11):1081–1091
87. Bruins P, te Velthuis H, Yazdanbakhsh AP et al (1997) Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 96(10):3542–3548
88. Cremer J, Martin M, Redl H et al (1996) Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg 61(6):1714–1720
89. Bolling SF, Pagani FD, Deeb GM, Bach DS (1998) Intermediate-term outcome of mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg 115(2):381–386 (discussion 7–8)
90. Butler J, Rocker GM, Westaby S (1993) Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 55(2):552–559
91. Lie JT, Pairolero PC, Holley KE, Titus JL (1975) Macroscopic enzyme-mapping verification of large, homogeneous, experimental myocardial infarcts of predictable size and location in dogs. J Thorac Cardiovasc Surg 69(4):599–605
92. Dake MD, Miller DC, Mitchell RS, Semba CP, Moore KA, Sakai T (1998) The “first generation” of endovascular stent-grafts for patients with aneurysms of the descending thoracic aorta. J Thorac Cardiovasc Surg 116(5):689–703 (discussion 4)
93. Waldo AL, MacLean WA, Karp RB, Kouchoukos NT, James TN (1977) Entrainment and interruption of atrial flutter with atrial pacing: studies in man following open heart surgery. Circulation 56(5):737–745
94. Daoud EG, Strickberger SA, Man KC et al (1997) Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med 337(25):1785–1791
95. Bigger JT, Jr (1997) Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary artery bypass graft (CABG) patch trial investigators. N Engl J Med 337(22):1569–1575
96. Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Starr A (1997) Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 63(2):356–361
97. Almassi GH, Schowalter T, Nicolosi AC, Aggarwal A, Moritz TE, Henderson WG et al (1997) Atrial fibrillation after cardiac surgery: a major morbid event? Ann Surg 226(4):501–511 (discussion 11–13)
98. King SB 3rd, Lembo NJ, Weintraub WS et al (1994) A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory angioplasty versus surgery trial (EAST). N Engl J Med 331(16):1044–1050
99. Svensson LG, Crawford ES, Hess KR et al (1993) Deep hypothermia with circulatory arrest. Determinants of stroke and early mortality in 656 patients. J Thorac Cardiovasc Surg 106(1):19–28 (discussion 31)
100. 1997 Coronary angioplasty versus medical therapy for angina: the second randomised intervention treatment of angina (RITA-2) trial. RITA-2 trial participants. Lancet 350(9076):461-468
101. Hammerschmidt DE, Stroncek DF, Bowers TK et al (1981) Complement activation and neutropenia occurring during cardiopulmonary bypass. J Thorac Cardiovasc Surg 81(3):370–377
102. Fisher LD, Kennedy JW, Davis KB et al (1982) Association of sex, physical size, and operative mortality after coronary artery bypass in the coronary artery surgery study (CASS). J Thorac Cardiovasc Surg 84(3):334–341
103. Aranki SF, Shaw DP, Adams DH et al (1996) Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation 94(3):390–397
104. 1997 Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the bypass angioplasty revascularization investigation (BARI). Circulation 96(6):1761–1769
105. Paparella D, Yau TM, Young E (2002) Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg. 21(2):232–244
106. Salzman EW, Weinstein MJ, Weintraub RM et al (1986) Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double-blind randomized trial. N Engl J Med 314(22):1402–1406
107. Hennein HA, Ebba H, Rodriguez JL et al (1994) Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg 108(4):626–635
108. van Dijk D, Nierich AP, Jansen EW et al (2001) Early outcome after off-pump versus on-pump coronary bypass surgery: results from a randomized study. Circulation 104(15):1761–1766
109. Frazier OH, Rose EA, Macmanus Q et al (1992) Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device. Ann Thorac Surg 53(6):1080–1090
110. Shake JG, Gruber PJ, Baumgartner WA (2002) Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg 73(6):1919–1925 (discussion 26)
111. Kennedy JW, Kaiser GC, Fisher LD et al (1980) Multivariate discriminant analysis of the clinical and angiographic predictors of operative mortality from the collaborative study in coronary artery surgery (CASS). J Thorac Cardiovasc Surg 80(6):876–887
112. Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD (2007) Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 116(22):2544–2552
113. Shlafer M, Kane PF, Kirsh MM (1982) Superoxide dismutase plus catalase enhances the efficacy of hypothermic cardioplegia to protect the globally ischemic, reperfused heart. J Thorac Cardiovasc Surg 83(6):830–839